Literature DB >> 10651996

Cutaneous metallothionein induction by ultraviolet B irradiation in interleukin-6 null mice.

N Nishimura1, V E Reeve, H Nishimura, M Satoh, C Tohyama.   

Abstract

The mediators of cutaneous metallothionein induction by ultraviolet radiation have not been defined. In this study we sought to identify cytokines that might be involved. We examined the role of interleukin-6, using the IL-6 null (IL-6-/-) mouse, which has been observed to be highly sensitive to ultraviolet radiation damage. Whereas cutaneous metallothionein concentration, measured by radioimmunoassay, began to rise in wild-type (IL-6+/+) mice by 12 h after ultraviolet irradiation, there was a significant delay in the IL-6-/- mice until 48 h after UV irradiation. Immunohistologically, metallothionein appeared in IL-6+/+ mice at 24 h in dermal fibroblasts, and then by 48 h in epidermal basal keratinocytes, with intensity increasing until 72 h, and was coincident with proliferating cell nuclear antigen-positive staining. Corresponding metallothionein expression in IL-6-/- mouse skin was significantly delayed. Serum interleukin-6 was elevated in IL-6+/+ mice following ultraviolet irradiation, with peak concentration at 4 h, but no increase in serum interleukin-1beta was found in either IL-6+/+ or IL-6-/- mice. Interestingly, tumor necrosis factor alpha concentration in serum was elevated at 12 h postirradiation in IL-6+/+ mice, but there was an earlier (at 4 and 8 h) time-dependent increase in tumor necrosis factor alpha in serum of the IL-6-/- mice. Skin zinc and copper concentrations were not altered by ultraviolet irradiation in either IL-6+/+ or IL-6-/- mice. The results suggest that interleukin-6 may be a very early mediator of cutaneous metallothionein induction by ultraviolet radiation, but that this role is possibly assumed by alternative cytokines like tumor necrosis factor alpha when interleukin-6 is deficient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10651996     DOI: 10.1046/j.1523-1747.2000.00862.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Estrogen receptor signaling protects against immune suppression by UV radiation exposure.

Authors:  Sitarina Widyarini; Diane Domanski; Nicole Painter; Vivienne E Reeve
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

2.  Interleukin-6 gene ablation in a transgenic mouse model of malignant skin melanoma.

Authors:  Verena von Felbert; Francisco Córdoba; Jakob Weissenberger; Claudio Vallan; Masashi Kato; Izumi Nakashima; Lasse Roger Braathen; Joachim Weis
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

3.  Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients.

Authors:  G Weinlich; K Eisendle; E Hassler; M Baltaci; P O Fritsch; B Zelger
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

4.  Autocrine Regulation of UVA-Induced IL-6 Production via Release of ATP and Activation of P2Y Receptors.

Authors:  Ayumi Kawano; Remi Kadomatsu; Miyu Ono; Shuji Kojima; Mitsutoshi Tsukimoto; Hikaru Sakamoto
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

Review 5.  Can skin exposure to sunlight prevent liver inflammation?

Authors:  Shelley Gorman; Lucinda J Black; Martin Feelisch; Prue H Hart; Richard Weller
Journal:  Nutrients       Date:  2015-05-05       Impact factor: 5.717

6.  Pathogenic and therapeutic role for NRF2 signaling in ultraviolet light-induced skin pigmentation.

Authors:  Michelle L Kerns; Robert J Miller; Momina Mazhar; Angel S Byrd; Nathan K Archer; Bret L Pinkser; Lance Lew; Carly A Dillen; Ruizhi Wang; Lloyd S Miller; Anna L Chien; Sewon Kang
Journal:  JCI Insight       Date:  2020-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.